Clarity Pharmaceuticals Ltd (CLRPF)
OTCMKTS · Delayed Price · Currency is USD
2.270
-0.035 (-1.52%)
Feb 11, 2026, 10:35 AM EST
Clarity Pharmaceuticals Market Cap
Clarity Pharmaceuticals has a market cap or net worth of $802.37 million as of February 12, 2026. Its market cap has increased by 8.84% in one year.
Market Cap
802.37M
Enterprise Value
742.50M
Revenue
6.20M
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.27
Market Cap Chart
Since August 25, 2021, Clarity Pharmaceuticals's market cap has increased from 278.91M to 802.37M, an increase of 187.68%. That is a compound annual growth rate of 26.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 802.37M | -4.34% |
| Dec 31, 2025 | 838.76M | 1.31% |
| Dec 31, 2024 | 827.89M | 143.75% |
| Dec 29, 2023 | 339.64M | 94.39% |
| Dec 30, 2022 | 174.72M | 26.78% |
| Dec 31, 2021 | 137.82M | -50.59% |
| Aug 25, 2021 | 278.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 406.62M |
| CytoDyn | 317.38M |
| Silence Therapeutics | 224.36M |
| Vaxart | 145.67M |
| HST Global | 139.70M |
| BioStem Technologies | 104.83M |
| Nuo Therapeutics | 80.63M |
| VitaSpring Biomedical | 51.78M |